Informations générales
Intitulé de l'offre : Fixed-term contract Engineer, biological engineer (M/F) (H/F)
Référence : UMR7284-MAEDUF-007
Nombre de Postes : 1
Lieu de travail : NICE
Date de publication : vendredi 5 décembre 2025
Type de contrat : IT en contrat CDD
Durée du contrat : 12 mois
Date d'embauche prévue : 1 février 2026
Quotité de travail : Complet
Rémunération : Gross monthly salary of €2,521 to €3,248 (depending on previous professional experience)
Niveau d'études souhaité : BAC+3/4
Expérience souhaitée : Indifférent
BAP : A - Sciences du vivant, de la terre et de l'environnement
Emploi type : Ingenieure ou ingenieur en techniques biologiques
Missions
The engineer's objective will be to validate the anti-tumour effect of pharmacological inhibitors developed by the 'Normal and Pathological Angiogenesis' research team.
Activités
- Conduct routine experiments in the field of biology: cell culture, biochemistry (immunoblotting, FACS, ELISA, etc.), molecular biology (qPCR, etc.).
- Conduct experiments on mice.
- Collect and format the results of experiments.
- Write and update technical protocols.
- Keep a laboratory notebook.
Compétences
- Knowledge and mastery of common experiments in the field of biology
- Training in animal experimentation
- Experience with experimental tumours in mice
- Highly autonomous in experimental work
- Motivated, dynamic, serious and diligent
Contexte de travail
The Laboratory is located on the Pasteur Hospital site, within the Faculty of Medicine. The team is affiliated with the Nice Institute for Research on Cancer and Ageing (IRCAN). IRCAN is a dynamic multidisciplinary institute comprising 17 independent research teams. The institute has state-of-the-art platforms in the fields of imaging, cytometry and genomic analysis.
The engineer will be assigned to the 'Normal and Pathological Angiogenesis' team under the supervision of Dr Gilles Pagès and will work closely with a researcher, Dr Maeva Dufies, an engineer, a PhD student and a post-doctoral researcher.
The team specialises in tumour vascularisation, treatment resistance and the development of new therapeutic strategies.
The team is composed of: 8 researchers, 2 postdoctoral researchers, 3 PhD students and 4 engineers.
Contraintes et risques
Conventional constraints associated with the use of biological and chemical materials